How is ENHERTU thought to work?
As a targeted treatment called an antibody-drug conjugate (ADC), ENHERTU is designed to work differently than traditional chemotherapies.
ENHERTU is made up of an antibody with the chemotherapy attached
The antibody part of ENHERTU targets and attaches to HER2 on the cancer cell
ENHERTU enters the cancer cell and the chemotherapy is released
The chemotherapy part of ENHERTU helps destroy the cancer cell as well as other cells nearby
Although ENHERTU is designed to target HER2 on cancer cells, it may affect some healthy cells.
ENHERTU may not work for everyone.